Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Hypopharyngeal Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT00588770
What this trial is testing

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Neck Squamous Cell Carcinoma of Unknown PrimaryRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+32 more
National Cancer Institute (NCI) 403
Large-scale testing (Phase 3)Active Not RecruitingNCT05063552
What this trial is testing

Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers

Who this might be right for
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+20 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00003582
What this trial is testing

Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer

Who this might be right for
Carcinoma of Unknown PrimaryHead and Neck Cancer
University of Miami 36
Testing effectiveness (Phase 2)Ended earlyNCT00573989
What this trial is testing

Intensity-Modulated Radiation Therapy, Pemetrexed, and Erlotinib in Treating Patients With Recurrent or Second Primary Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Wake Forest University Health Sciences 27
Testing effectiveness (Phase 2)Study completedNCT00020189
What this trial is testing

Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck CancerThromboembolism
National Cancer Institute (NCI)
Not applicableLooking for participantsNCT00898638
What this trial is testing

Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants

Who this might be right for
Head and Neck Cancer
Vanderbilt University Medical Center 8,000
Early research (Phase 1)Study completedNCT01254617
What this trial is testing

Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer

Who this might be right for
Recurrent Colon CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+39 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00507767
What this trial is testing

Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+33 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT00002922
What this trial is testing

Paclitaxel in Treating Patients With Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Looking for participantsNCT04198766
What this trial is testing

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Who this might be right for
Solid TumorNon-Small Cell Lung CancerHead and Neck Cancer+5 more
Inhibrx Biosciences, Inc 340
Testing effectiveness (Phase 2)UnknownNCT00003257
What this trial is testing

Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Aventis Pharmaceuticals 39
Not applicableUnknownNCT00173381
What this trial is testing

The Role of Lymphangiogenesis in Head and Neck Cancer Metastasis

Who this might be right for
Oral CancerLaryngeal CancerHypopharyngeal Cancer
National Taiwan University Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00639769
What this trial is testing

Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 41
Not applicableStudy completedNCT00973947
What this trial is testing

Customized Headrest or Standard Headrest in Holding Patients Still While Undergoing Radiation Therapy for Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Cancer Trials Ireland 40
Not applicableUnknownNCT00302562
What this trial is testing

The Role of MMPs in the CXCL12-Induced Invasion of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma

Who this might be right for
Laryngeal CancerHypopharyngeal Cancer
National Taiwan University Hospital 100
Testing effectiveness (Phase 2)Ended earlyNCT02062632
What this trial is testing

Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy

Who this might be right for
Esophageal CarcinomaHypopharyngeal CarcinomaLaryngeal Carcinoma+11 more
Mayo Clinic 5
Large-scale testing (Phase 3)Study completedNCT00003809
What this trial is testing

Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00003565
What this trial is testing

Docetaxel in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerHead and Neck Cancer+2 more
Alliance for Clinical Trials in Oncology 109
Testing effectiveness (Phase 2)Study completedNCT00068237
What this trial is testing

Salivary Gland Surgery Before Radiation Therapy in Preventing Radiation-Caused Xerostomia in Patients With Head and Neck Cancer

Who this might be right for
Head and Neck CancerRadiation ToxicityXerostomia
Radiation Therapy Oncology Group 49
Early research (Phase 1)WithdrawnNCT00006106
What this trial is testing

ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer

Who this might be right for
Lip and Oral Cavity CancerHead and Neck CancerOropharyngeal Cancer
National Cancer Institute (NCI)
Next Page
430